Search

everythinglearnresearchcommunity

for

Search:↓

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Women with excessive hair growth or polycystic ovary disease may more often carry a gene variant for 21 hydroxylase deficiency.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Type 2 5α-reductase plays a key role in hair loss.

Cushing syndrome often causes low testosterone and sexual issues in men.

5-alpha reductase inhibitors are generally safe but can cause sexual side effects and require patient education on risks.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.

Lowering certain hormone levels improves treatment for hair loss in young men.

Drospirenone can hide symptoms of certain hormonal disorders, complicating diagnosis.

Androgenetic alopecia is not linked to higher risks of hypertension or hyperaldosteronism.

Men taking dutasteride may have a higher risk of age-related macular degeneration.

The chemicals 17βC and its methyl ester can block the effects of testosterone on hamster skin but not the effects of DHT.

Cyproterone acetate treatment is safe and causes mild feminization, which increases with added estrogen.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

SHBG binding properties are unchanged in male liver cirrhosis patients.

Excessive hair growth in women can be treated with medications like spironolactone and finasteride, and male-pattern baldness in women can be improved with similar treatments.

Androgen measurement helps diagnose PCOS, but accuracy varies, needing standard methods.

Finasteride improves hair loss in women with hyperandrogenism.

Finasteride helps reduce hidradenitis suppurativa symptoms in females.

Women with PCOS have higher 5alpha-reductase activity, affecting steroid levels.

Early hormones shape sex-specific differences in rat glands.

The risks of testosterone implants in women outweigh the benefits.

The treatment significantly reduced hair growth and male hormone levels in hirsute women.

5α-reductase inhibitors help manage symptoms of benign prostatic hyperplasia and may also prevent prostate cancer and treat hair loss.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction, but the exact reasons are unclear.

A 68-year-old woman developed male traits due to a tumor in her ovary, which was removed, returning her hormone levels to normal.

Some medications for bladder problems can cause memory issues or mood changes, and doctors should monitor these side effects.

The enzyme type 1 5α-reductase is more active in the hair follicle's lower part than in the skin's outer layer.